SHP-77 (ATCC® CRL-2195)

Organism: Homo sapiens, human  /  Cell Type: epithelial  /  Tissue: lung  /  Disease: carcinoma; small cell lung cancer

Permits and Restrictions

View Permits

Organism Homo sapiens, human
Tissue lung
Cell Type epithelial
Product Format frozen
Morphology epithelial
Culture Properties suspension and loosely adherent
Biosafety Level 1
Disease carcinoma; small cell lung cancer
Age 54 years
Gender male
Ethnicity Caucasian
Applications
SHP-77 can serve as an in vitro target in 51Cr and 111In release cytotoxicity assays as well as in vivo nude mice assays for evaluating immune reactivity of cells and serum from lung cancer patients.
The cells can be used to evaluate the immune status of patients with SCLC who are treated with radiation or chemotherapy.
 
Storage Conditions liquid nitrogen vapor phase
Derivation
It was established in 1977 by Edwin R. Fisher and John D. Paulson.
The line was derived from a non-encapsulated primary lung tumor from the apical portion of the upper lobe of the left lung.
Clinical Data
54 years
Caucasian
male
Antigen Expression
Blood Type O; Rh +; CD56; CD57 (HNK-1,Leu-7)
Genes Expressed
neural cell adhesion molecule (NCAM) NKH-1
Cellular Products
neural cell adhesion molecule (NCAM) NKH-1
Tumorigenic Yes
Effects
Yes, the cells form tumors in athymic nude mice, and usually grow as circumscribed nodules without evidence of metastases
Comments

The SHP-77 (Shadyside Hospital, Pittsburgh, PA) cell line is a biochemically stable continuously cultured cell line which has retained important features of SCLC.

This cell line is an unusual undifferentiated large cell variant of small cell lung carcinoma.

It has the morphology of a variant, but the biochemical properties of a classic SCLC.

Electron microscopy revealed the presence of gland formation and intracytoplasmic lamellar bodies.

The cells have neuroendocrine markers L-dopa decarboxylase and dense core secretory granules.

SHP-77 can serve as an in vitro target in 51Cr and 111In release cytotoxicity assays as well as in vivo nude mice assays for evaluating immune reactivity of cells and serum from lung cancer patients.

The cells can be used to evaluate the immune status of patients with SCLC who are treated with radiation or chemotherapy.
Complete Growth Medium The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: heat-inactivated fetal bovine serum to a final concentration of 10%.
Subculturing Cultures can be maintained by addition or replacement of fresh medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at approximately 4-5 x 105 viable cells/mL. Cells will grow in floating clusters. Some cells may adhere but only the floating cells are transferred.

Medium Renewal: Every 3 to 4 days
Cryopreservation
Culture medium, 95%; DMSO, 5%
Culture Conditions
Temperature: 37°C
STR Profile
Amelogenin: X
CSF1PO: 10,11
D13S317: 8
D16S539: 11
D5S818: 12
D7S820: 11
THO1: 7
TPOX: 9,11
vWA: 16
Population Doubling Time 96 hrs
Name of Depositor AM Koros
Year of Origin 1977
References

. Immune-deficient animals. Basel: Karger; 1984.

. . J. Exp. Clin. Res. 4: 355-363, 1985.

Fisher ER, et al. Comparative histopathologic, histochemical, electron microscopic and tissue culture studies of bronchial carcinoids and oat cell carcinomas of lung. Am. J. Clin. Pathol. 69: 165-172, 1978. PubMed: 204185

Koros AM, et al. Stability and utility of the unique human small cell carcinoma line SHP-77. Cancer Res. 45: 2725-2731, 1985. PubMed: 2985251

Carbone DP, et al. Neural cell adhesion molecule expression and messenger RNA splicing patterns in lung cancer cell lines are correlated with neuroendocrine phenotype and growth morphology. Cancer Res. 51: 6142-6149, 1991. PubMed: 1718595

Fisher ER, Paulson JD. A new in vitro cell line established from human large cell variant of oat cell lung cancer. Cancer Res. 38: 3830-3835, 1978. PubMed: 212181

Koros AM, et al. 186Rhenium-HNK1 monoclonal antibody targets human small cell lung cancer cells in athymic nude mice: rapid screening model for therapy. Anticancer Res. 13: 1953-1956, 1993. PubMed: 7507652

Koros. Monoclonal antibodies directed against small cell carcinomas define by flow cytometry phenotypic differences among small cell and non-small cell carcinomas, neuroblastomas, and lymphoblastoid cell lines. Lung Cancer 4: 52-54, 1988.

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation
References

. Immune-deficient animals. Basel: Karger; 1984.

. . J. Exp. Clin. Res. 4: 355-363, 1985.

Fisher ER, et al. Comparative histopathologic, histochemical, electron microscopic and tissue culture studies of bronchial carcinoids and oat cell carcinomas of lung. Am. J. Clin. Pathol. 69: 165-172, 1978. PubMed: 204185

Koros AM, et al. Stability and utility of the unique human small cell carcinoma line SHP-77. Cancer Res. 45: 2725-2731, 1985. PubMed: 2985251

Carbone DP, et al. Neural cell adhesion molecule expression and messenger RNA splicing patterns in lung cancer cell lines are correlated with neuroendocrine phenotype and growth morphology. Cancer Res. 51: 6142-6149, 1991. PubMed: 1718595

Fisher ER, Paulson JD. A new in vitro cell line established from human large cell variant of oat cell lung cancer. Cancer Res. 38: 3830-3835, 1978. PubMed: 212181

Koros AM, et al. 186Rhenium-HNK1 monoclonal antibody targets human small cell lung cancer cells in athymic nude mice: rapid screening model for therapy. Anticancer Res. 13: 1953-1956, 1993. PubMed: 7507652

Koros. Monoclonal antibodies directed against small cell carcinomas define by flow cytometry phenotypic differences among small cell and non-small cell carcinomas, neuroblastomas, and lymphoblastoid cell lines. Lung Cancer 4: 52-54, 1988.